SGLD.L
Invesco Physical Gold ETC
LSEUSDEQUITY
DELAYED
Last price
443.13
▲ 7.90 (1.82%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
435.23
Day high
443.20
Day low
438.55
Volume
52.26K
Market cap
—
P/E (TTM)
—
52W range
308.55 – 534.03
Trailing performance
Returnvs SPY
1W
+4.93%
+6.3%
1M
+13.79%
+10.1%
3M
+2.20%
-0.9%
6M
-9.11%
-20.2%
YTD
+6.82%
-5.5%
1Y
+36.18%
+16.2%
3Y
+140.50%
+66.3%
5Y
+153.44%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SGLD.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $850.20M | $1.03B | $1.09B | $1.14B | -17.2% |
| Operating revenue | $850.20M | $1.03B | $1.09B | $1.14B | -17.2% |
| Cost of revenue | $652.10M | $797.50M | $853.50M | $882.30M | -18.2% |
| Gross profit | $198.10M | $228.90M | $235.60M | $253.60M | -13.5% |
| Research & development | $20.00M | $25.70M | $29.70M | $29.30M | -22.2% |
| Selling, general & admin | $109.10M | $126.00M | $136.40M | $148.80M | -13.4% |
| Total operating expense | $125.80M | $144.20M | $143.60M | $169.30M | -12.8% |
| Operating income | $72.30M | $84.70M | $92.00M | $84.30M | -14.6% |
| Net interest income | -$32.30M | -$32.50M | -$34.20M | -$27.70M | +0.6% |
| Pre-tax income | -$41.60M | -$46.90M | $22.40M | $94.60M | +11.3% |
| Tax provision | $36.70M | $32.50M | -$19.30M | -$31.30M | +12.9% |
| Net income | -$79.20M | -$80.30M | $41.00M | $126.90M | +1.4% |
| Net income to common | -$79.20M | -$80.30M | $41.00M | $126.90M | +1.4% |
| Basic EPS | -0.65 | -0.66 | 0.34 | 1.04 | +1.5% |
| Diluted EPS | -0.65 | -0.66 | 0.34 | 1.02 | +1.5% |
| EBIT | -$6.00M | -$8.40M | $61.30M | $122.90M | +28.6% |
| EBITDA | $48.40M | $51.50M | $121.50M | $189.60M | -6.0% |
| Basic shares | 122.27M | 122.27M | 122.27M | 122.27M | 0.0% |
| Diluted shares | 146.73M | 122.27M | 122.27M | 133.64M | +20.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $148.90M | $148.00M | $199.40M | $227.30M | +0.6% |
| Cash & short-term investments | $150.00M | $155.30M | $201.50M | $229.70M | -3.4% |
| Accounts receivable | $65.70M | $76.90M | $71.20M | $114.90M | -14.6% |
| Inventory | $297.10M | $345.60M | $373.60M | $324.00M | -14.0% |
| Total current assets | $587.40M | $673.90M | $757.00M | $787.30M | -12.8% |
| Property, plant & equipment | $422.30M | $461.30M | $517.50M | $532.70M | -8.5% |
| Goodwill & intangibles | $28.80M | $34.50M | $35.40M | $37.90M | -16.5% |
| Total assets | $1.17B | $1.34B | $1.47B | $1.48B | -12.7% |
| Total current liabilities | $214.90M | $243.30M | $274.40M | $300.90M | -11.7% |
| Current debt | $5.20M | $5.20M | $3.00M | $34.90M | 0.0% |
| Long-term debt | $227.00M | $226.10M | $279.80M | $342.50M | +0.4% |
| Total debt | $255.50M | $256.10M | $308.80M | $397.30M | -0.2% |
| Total liabilities | $700.40M | $772.30M | $857.70M | $901.70M | -9.3% |
| Retained earnings | -$923.80M | -$826.10M | -$775.70M | -$797.40M | -11.8% |
| Shareholder equity | $457.20M | $554.90M | $605.30M | $569.30M | -17.6% |
| Working capital | $372.50M | $430.60M | $482.60M | $486.40M | -13.5% |
| Net tangible assets | $428.40M | $520.40M | $569.90M | $531.40M | -17.7% |
| Shares issued | 122.34M | 122.34M | 122.34M | 122.34M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$41.60M | -$46.90M | $22.40M | $94.60M | +11.3% |
| Depreciation & amortisation | $54.40M | $59.90M | $60.20M | $66.70M | -9.2% |
| Change in working capital | $33.60M | $9.40M | $45.90M | -$7.70M | +257.4% |
| Operating cash flow | $79.20M | $120.30M | $163.80M | $94.40M | -34.2% |
| Capital expenditure | -$53.60M | -$97.30M | -$87.10M | -$52.90M | +44.9% |
| Investing cash flow | -$72.20M | -$34.40M | -$133.20M | -$26.60M | -109.9% |
| Financing cash flow | -$32.90M | -$90.50M | -$121.70M | -$60.10M | +63.6% |
| Free cash flow | $25.60M | $23.00M | $76.70M | $41.50M | +11.3% |
| End cash position | $103.00M | $130.20M | $134.40M | $227.30M | -20.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $184.50M | $197.30M | $199.70M | $218.90M | $234.30M | -6.5% |
| Operating revenue | $184.50M | $197.30M | $199.70M | $218.90M | $234.30M | -6.5% |
| Cost of revenue | $142.50M | $155.50M | $150.70M | $164.80M | $181.10M | -8.4% |
| Gross profit | $42.00M | $41.80M | $49.00M | $54.10M | $53.20M | +0.5% |
| Research & development | $5.20M | $4.60M | $4.80M | $4.90M | $5.70M | +13.0% |
| Selling, general & admin | $25.80M | $26.40M | $24.80M | $28.30M | $29.60M | -2.3% |
| Total operating expense | $28.70M | $30.30M | $27.30M | $33.40M | $34.80M | -5.3% |
| Operating income | $13.30M | $11.50M | $21.70M | $20.70M | $18.40M | +15.7% |
| Net interest income | -$8.90M | -$9.80M | -$7.10M | -$6.70M | -$7.20M | +9.2% |
| Pre-tax income | $6.20M | -$5.70M | -$19.20M | -$13.30M | -$3.40M | +208.8% |
| Tax provision | $100.00K | $22.00M | $500.00K | $11.70M | $2.50M | -99.5% |
| Net income | $5.90M | -$27.90M | -$19.90M | -$25.30M | -$6.10M | +121.1% |
| Net income to common | $5.90M | -$27.90M | -$19.90M | -$25.30M | -$6.10M | +121.1% |
| Basic EPS | 0.05 | — | -0.16 | -0.21 | -0.05 | — |
| Diluted EPS | 0.05 | — | -0.16 | -0.21 | -0.05 | — |
| EBIT | $15.00M | $5.90M | -$11.10M | -$5.30M | $4.50M | +154.2% |
| EBITDA | $27.20M | $20.40M | $2.50M | $7.90M | $17.60M | +33.3% |
| Basic shares | 118.00M | — | 124.38M | 120.48M | 122.00M | — |
| Diluted shares | 118.00M | — | 124.38M | 120.48M | 122.00M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $147.30M | $148.90M | $136.90M | $139.20M | $145.20M | -1.1% |
| Cash & short-term investments | $147.30M | $150.00M | $136.90M | $139.20M | $145.20M | -1.8% |
| Accounts receivable | $114.50M | $65.70M | $128.60M | $137.30M | $155.90M | +74.3% |
| Inventory | $306.10M | $297.10M | $310.70M | $331.90M | $347.40M | +3.0% |
| Total current assets | $592.00M | $587.40M | $599.20M | $634.20M | $680.00M | +0.8% |
| Property, plant & equipment | $421.30M | $422.30M | $425.80M | $439.90M | $451.40M | -0.2% |
| Goodwill & intangibles | $28.90M | $28.80M | $30.30M | $31.20M | $33.40M | +0.3% |
| Total assets | $1.18B | $1.17B | $1.20B | $1.25B | $1.32B | +0.7% |
| Total current liabilities | $203.90M | $214.90M | $205.90M | $237.50M | $253.00M | -5.1% |
| Current debt | $5.20M | $5.20M | $7.60M | $7.60M | $6.50M | 0.0% |
| Long-term debt | $226.50M | $227.00M | $226.10M | $225.60M | $225.20M | -0.2% |
| Total debt | $231.70M | $255.50M | $233.70M | $233.20M | $231.70M | -9.3% |
| Total liabilities | $701.60M | $700.40M | $714.90M | $743.70M | $766.80M | +0.2% |
| Retained earnings | -$917.10M | -$923.80M | -$904.80M | -$883.90M | -$834.80M | +0.7% |
| Shareholder equity | $463.90M | $457.20M | $476.20M | $497.10M | $546.20M | +1.5% |
| Working capital | $388.10M | $372.50M | $393.30M | $396.70M | $427.00M | +4.2% |
| Net tangible assets | $435.00M | $428.40M | $445.90M | $465.90M | $512.80M | +1.5% |
| Shares issued | 122.27M | 122.34M | 122.27M | 122.34M | 122.27M | -0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $6.20M | -$5.70M | -$19.20M | -$13.30M | -$3.40M | +208.8% |
| Depreciation & amortisation | $12.20M | $14.50M | $13.60M | $13.20M | $13.10M | -15.9% |
| Change in working capital | -$1.20M | $43.40M | $1.50M | -$8.70M | -$2.60M | -102.8% |
| Operating cash flow | $13.50M | $39.10M | $15.80M | $13.50M | $10.80M | -65.5% |
| Capital expenditure | -$7.30M | -$15.40M | -$11.90M | -$12.10M | -$14.20M | +52.6% |
| Investing cash flow | -$7.10M | -$34.60M | -$20.60M | -$11.30M | -$5.70M | +79.5% |
| Financing cash flow | -$8.40M | -$10.40M | -$7.40M | -$7.60M | -$7.50M | +19.2% |
| Free cash flow | $6.20M | $23.70M | $3.90M | $1.40M | -$3.40M | -73.8% |
| End cash position | $101.30M | $103.00M | $109.10M | $121.40M | $127.40M | -1.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
426.15
+3.98% from price
SMA 20
411.35
+7.73% from price
SMA 50
401.94
+10.25% from price
SMA 100
422.06
+4.99% from price
SMA 200
433.52
+2.22% from price
EMA 12
423.67
+4.59% from price
EMA 26
413.64
+7.13% from price
EMA 50
411.50
+7.69% from price
RSI (14)
71.6
Overbought
MACD (12,26,9)
10.02
Hist 3.20
ATR (14)
7.80
1.76% of price
Realised vol 30D
24.0%
Annualised
Bollinger upper
446.36
20, 2σ
Bollinger lower
376.34
20, 2σ
50 / 200 cross
Death
401.94 vs 433.52
Trend bias
Above 200
+2.22%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.27
Less volatile than market
Correlation to SPY
0.13
Largely independent
Realised vol 30D
24.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.4%
Peak to trough
Max drawdown 5Y
-24.4%
Peak to trough
ATR 14
7.80
1.76% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
3 Unpopular Stocks We Steer Clear Of
StockStory · 9m ago
Oleria and Happiest Minds Partner to Accelerate Modern Identity Governance for AI-First Enterprises
ACCESS Newswire · 11m ago
Vicore Pharma to Present at the European Respiratory Society Congress 2026
ACCESS Newswire · 11m ago
Dollar trading near multi-month lows, restrained by debt nerves
Reuters · 12m ago
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 21m ago
TME Pharma provides update on its activities
GlobeNewswire · 21m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 26m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 26m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.